Cargando…

Impact of the COVID-19 pandemic and the dynamic COVID-zero strategy on HIV incidence and mortality in China

BACKGROUND: In response to the coronavirus disease 2019 (COVID-19) pandemic, the Chinese government implemented the dynamic COVID-zero strategy. We hypothesized that pandemic mitigation measures might have reduced the incidence, mortality rates, and case fatality ratios (CFRs) of the human immunodef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lan, Zhao, Na, Wang, Yuliang, Sun, Kaili, Wang, Yike, Huang, Shufang, Yao, Feng, Guo, Xiangyu, Yang, Yunmei, Ma, Chenjin, Liu, Shelan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938685/ https://www.ncbi.nlm.nih.gov/pubmed/36800946 http://dx.doi.org/10.1186/s12889-023-15268-9

Ejemplares similares

The impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China
por: Ma, Chenjin, et al.
Publicado: (2022)

The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China
por: Guo, Xiangyu, et al.
Publicado: (2022)

Collateral Impact of COVID-19 Prevention Measures on Re-Emergence of Scarlet Fever and Pertussis in Mainland China and Hong Kong China
por: He, Yiran, et al.
Publicado: (2022)

The Effect of Coronavirus 2019 Disease Control Measures on the Incidence of Respiratory Infectious Disease and Air Pollutant Concentrations in the Yangtze River Delta Region, China
por: Wang, Lan, et al.
Publicado: (2022)

The Dynamic COVID-Zero Strategy in China
por: Liu, Jue, et al.
Publicado: (2022)

Decreased incidence of acute hemorrhagic conjunctivitis associated with enhanced public health intervention during the COVID-19 epidemic in China, 2020
por: Zhang, Li, et al.
Publicado: (2022)

Investigation on the possibility of dynamic COVID-Zero strategy in China: a population-based transmission model analysis and economic evaluation
por: Wang, Xuechun, et al.
Publicado: (2023)

Excess All-Cause Mortality in China After Ending the Zero COVID Policy
por: Xiao, Hong, et al.
Publicado: (2023)

The Advantages of the Zero-COVID-19 Strategy
por: Su, Zhaohui, et al.
Publicado: (2022)

Zero-Covid Strategy: What’s Next?
por: Zhan, Zhiqing, et al.
Publicado: (2022)

Zero COVID in China: what next?
por: Yuan, Shawn
Publicado: (2022)

Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021
por: Wang, Lianhao, et al.
Publicado: (2022)

China's ‘dynamic zero COVID-19 strategy’ will face greater challenges in the future
por: Cai, Juncheng, et al.
Publicado: (2022)

Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis
por: Tan, Chongqing, et al.
Publicado: (2023)

Epidemiological characteristics of seasonal influenza under implementation of zero-COVID-19 strategy in China
por: Zeng, Hui, et al.
Publicado: (2023)

Modelling the reopen strategy from dynamic zero-COVID in China considering the sequela and reinfection
por: Wu, Sijin, et al.
Publicado: (2023)

Optimizing the dynamic zero-COVID policy in China
por: Bai, Wei, et al.
Publicado: (2022)

Moving away from zero COVID in China
por: Burki, Talha
Publicado: (2023)

Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey
por: Qin, Shijie, et al.
Publicado: (2023)

Persevere in the Dynamic COVID-Zero Strategy in China to Gain a Precious Time Window for the Future
por: Liu, Jue, et al.
Publicado: (2022)

The end of zero-COVID-19 policy is not the end of COVID-19 for China
por: The Lancet Regional Health – Western Pacific
Publicado: (2023)

Epidemiological features and trends in the mortality rates of 10 notifiable respiratory infectious diseases in China from 2004 to 2020: Based on national surveillance
por: Zhao, Na, et al.
Publicado: (2023)

Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study
por: Zhao, Na, et al.
Publicado: (2023)

Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy
por: Wan, Zhenzhou, et al.
Publicado: (2022)

Cost-effectiveness analysis of COVID-19 screening strategy under China's dynamic zero-case policy
por: Li, Haonan, et al.
Publicado: (2023)

Quantifying the rebound of influenza epidemics after the adjustment of zero-COVID policy in China
por: Lei, Hao, et al.
Publicado: (2023)

The COVID-19 pandemic in China: from dynamic zero-COVID to current policy
por: Ge, Junbo
Publicado: (2023)

Impact of the first wave of COVID-19 on Crohn’s disease after the end of “zero-COVID” policy in China
por: Hu, Wen, et al.
Publicado: (2023)

China's community-based crisis management model for COVID-19: A zero-tolerance approach
por: Shangguan, Ziheng, et al.
Publicado: (2022)

Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy
por: Ioannidis, John P.A., et al.
Publicado: (2023)

Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China
por: Li, Hongdou, et al.
Publicado: (2020)

Commentary: China's Zero-COVID Approach Depends on Shanghai's Outbreak Control
por: Cheshmehzangi, Ali, et al.
Publicado: (2022)

Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis
por: Zhang, Chaobao, et al.
Publicado: (2022)

Assessing the mechanism of citywide test-trace-isolate Zero-COVID policy and exit strategy of COVID-19 pandemic
por: Yuan, Pei, et al.
Publicado: (2022)

Towards zero perioperative mortality
por: Landoni, G, et al.
Publicado: (2013)

A multicentre study on the incidence of respiratory viruses in children with community-acquired pneumonia requiring hospitalization in the setting of the zero-COVID policy in China
por: Feng, Ziheng, et al.
Publicado: (2023)

Incidence and risk factors for AIDS-related mortality in HIV patients in China: a cross-sectional study
por: Zheng, Hui, et al.
Publicado: (2014)

The echo chamber effect of rumor rebuttal behavior of users in the early stage of COVID-19 epidemic in China
por: Wang, Dandan, et al.
Publicado: (2022)

Eliminating HIV & AIDS in India: A roadmap to zero new HIV infections, zero discrimination & zero AIDS-related deaths
por: Palchaudhuri, Riya, et al.
Publicado: (2016)

Challenges to HIV Care and Psychological Health During the COVID-19 Pandemic Among People Living with HIV in China
por: Sun, Shufang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_78qu2mm3dl37fq94bpb7kmanbt